Treatment was not associated with changes in any of the PFT outcomes over the treatment period (data not shown)
Inconsistent communication Most platforms offer little to no clinical communication, leading to confusion and poor outcomes
We encourage you to take ownership of your health through education
The SELECT trial result - 20% reduction in major cardiovascular events with weekly semaglutide 2.4mg in adults with established cardiovascular disease plus overweight/obesity - was the first time a weight-loss medication demonstrated cardiovascular outcome benefits in a major randomized controlled trial
Glutathione and Detoxification: Because of glutathiones central role in detoxification, about 25% of all glutathione resides in the liver
Okay Moyad, you have always said over the past 30+ years that everything comes with a catch, so what is the catch with semaglutide? Well, I am glad you asked me this question, because it does not come with a catch, but CATCHES